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The indices of body size and aggressiveness of papillary 
thyroid carcinoma
Ju-Yeon Kim, Eun-Jung Jung, Sang-Ho Jeong, Chi-Young Jeong, Young-Tae Ju, Young-Jun Lee, 
Soon-Chan Hong, Sang-Kyeong Choi, Woo-Song Ha, Soon-Tae Park
Department of Surgery, Gyeongsang National University School of Medicine, Jinju, Korea
Purpose: The incidence of papillary thyroid carcinoma (PTC) is increasing worldwide. Positive associations between indices 
of body size and thyroid cancer have been reported. However, the relationships to cancer severities and/or behaviors are 
uncertain. Methods: We performed a retrospective analysis of the data of patients who underwent total thyroidectomy due to 
PTC. The epidemiologic factor and pathologic report after operation were determined based on chart review. The relation-
ships between indices of body size and these parameters were assessed. Results: Positive association between body mass in-
dex and T stage was found, but it was not statically significant. In neck lymph node metastasis, the group with metastasis had 
a tendency for larger mean height and weight, but significant difference was found only in height. However, in the multi-
variate analysis, the age and size of nodules were only identified as independent risk factors of neck lymph node metastasis 
(P = 0.000 and 0.019). Conclusion: There was no independent association between indices of body size and stages of PTC in 
patients who underwent total thyroidectomy.
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INTRODUCTION
The incidence of papillary thyroid carcinoma (PTC), 
which is the most common histologic type of thyroid ma-
lignancy, is increasing worldwide [1]. High cure rates are 
achieved after initial treatment of patients who develop 
PTC. How ev er , some patients are at a high risk of re-
currence and even of death. Many publications have been 
devoted to finding prognostic factors for PTC, focusing on 
epidemiological, biological, clinical and pathological data 
[2-5].
In recent years, positive associations between height, 
weight and body mass index (BMI) and PTC have been re-
ported [6-13]. The World Cancer Research Fund (WCRF) 
report concludes to a potential association between thy-
roid cancer and body size, possibly through changes in io-
dine requirement [14]. 
Most of these studies have looked into the etiology of 
thyroid cancer by comparing with healthy controls, how-
ever, it is unclear whether prognostic role of the body size 
in the severity and recurrence of PTC. Recently, Paes et al. 
[15] suggested that obesity may be correlated with a less 
aggressive tumor invasion, however it was not significant. 
Thus, more studies on effects of obesity for the thyroid Ju-Yeon Kim, et al.
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Table 1. The characteristics of the 315 patients 
Characteristics Value
Sex (M:F) 47:268
Age (yr)   51.09 ± 13.7
　＜45 101 (32.06)
　≥45 214 (67.94)
Body size 
　Height (cm) 159.17 ± 7.98
　Weight (kg)   62.16 ± 9.91
　BMI (kg/m
2)   24.51 ± 3.20
Pathologic results 
　T1/T2/T3/T4 125/9/167/14
　N0/N1 194/121
Values are presented as mean ± SD or number (%).
BMI, body mass index.
Table 2. Relationship between indices of body size and T stage
T1 T2 T3 T4 P-value
Height (cm) 159.89 ± 7.47 161.87 ± 6.29 158.28 ± 8.03 161.73 ± 11.44 0.069
Weight (kg)     62.26 ± 10.26   64.04 ± 9.26 61.55 ± 9.49   67.53 ± 11.22 0.812
BMI (kg/m
2)   24.31 ± 3.27  24.37 ± 2.55 24.55 ± 3.19 25.87 ± 3.02 0.664
Values are presented as mean ± SD. 
BMI, body mass index.
cancer are needed.
In this study, we aimed to examine the association of in-
dices of body size with aggressiveness and recurrence of 
PTC. So, we performed a retrospective investigation of the 
body size and cancer characteristics of patients who un-
derwent total thyroidectomy PTC in our hospital. 
METHODS
We reviewed the charts of the persons who underwent 
a health examination from January 2007 to December 2009 
in Health Examination Center of Gyeongsang National 
University. Among these, the patients who underwent to-
tal thyroidectomy for PTC were selected for the study. In 
each operation, when lymph node metastasis was sus-
pected from the preoperative or intraoperative findings, 
central neck and/or lateral neck lymph node dissection 
were performed. 
The epidemiologic factor and pathologic report after 
operation were determined based on chart review. Tumor- 
node-metastasis stage was based on the American Joint 
Committee on Cancer cancer staging manual seventh edi-
tion [16]. For each patients, the height and weight reported 
in the anesthesia summary was used to calculate the BMI 
according to its determined formula (i.e., BMI = weight 
[kg] / height [m
2]).
All data are expressed as mean ( ± standard deviation). 
The SPSS (SPSS Inc., Chicago, IL, USA) was used for stat-
istical analysis, and the one way analysis of variance test 
and chi-square test were used to compare the indices of 
body size and other parameters between T and N stage 
sub-groups.
Multivariate analysis was performed with logic re-
gression analysis to identify the independent predictors of 
lymph node metastasis. P ＜  0.05 was considered statisti-
cally significant.
RESULTS
A total of 315 PTC patients (47 men and 268 women) 
were studied. The mean age was 51.09 years (range, 12 to 
88 years). The mean BMI was 24.51 ± 3.20 kg/m
2 and 133 
patients (42.2%) had a BMI same or higher than 25 kg/m
2. 
One hundred seventh-nine patients (56.8%) had nodules 
which were extrathyroidal extension, and 121 patients had 
regional lymph node metastasis (Table 1).
Body size and T stage
The correlation between the body size and T stage is 
shown in Table 2. Although positive association between 
BMI and T stage was found, it was not statically signi-
ficant. The mean age of T1 and T2 (49.4 ± 12.37 years old) 
was significantly lower than that of T3 and T4 (52.34 ± 
13.46 years old, P = 0.046).Body size and papillary thyroid carcinoma
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Table 3. Relationship between indices of body size and N stage
N0 N1 P-value
Height (cm) 158.38 ± 6.88 160.44 ± 9.37 0.026
Weight (kg)   61.58 ± 8.95     63.09 ± 11.24 0.189
BMI (kg/m
2)   24.56 ± 3.23   24.44 ± 3.14 0.741
Values are presented as mean ± SD. 
BMI, body mass index.
Body size and lymph node metastasis
A total of 124 patients had neck lymph node metastasis: 
87 patients had only central neck lymph node metastasis, 
7 patients had only lateral neck lymph node metastasis 
and 26 patients had both central and lateral neck lymph 
node metastasis. The higher rates of lymph node meta-
stasis were seen in men when compared to women (55.3% 
vs. 35.4%, P = 0.014). And, the patients with lymph node 
metastasis were younger than patients of non-metastasis 
(48.93 years old vs. 52.44 years old, P = 0.020).
In the patients who were founded to have neck lymph 
node metastasis, the mean height and weight were larger 
than the others, but significant difference were founded 
only on height (Table 3). A multivariate analysis was con-
ducted to find factors affecting the metastasis of neck 
lymph nodes, and age and size of nodules were only iden-
tified as independent risk factors (P = 0.000 and 0.019).
Body size and recurrence 
After a median follow-up of 23.6 months (range, 9 to 44 
months), 7 patients showed tumor recurrence in neck 
lymph nodes. There were no statistically significant corre-
lations between the body size and the existence of recur-
rence. 
DISCUSSION
Recently many studies on the correlations between thy-
roid cancer and height, weight, and BMI have been pub-
lished [6,11,17,18]. However, great heterogeneity exists 
among studies as to the actual association between body 
size and thyroid malignancy. The WCRF report concludes 
to a potential association between thyroid cancer and 
body size, possibly through changes in iodine require-
ment [14]. Renehan et al. [8] conducted a meta-analysis of 
five prospective studies on thyroid cancer and BMI, and 
reported that the risk of thyroid cancer for each increase of 
5 in BMI among men and women were 1.52 and 1.14, 
respectively. According to a study by Sung et al. [18] on the 
development of various cancers by height, the greater the 
height, the higher the frequency of thyroid cancer became 
for both men and women. 
Studies have been carried out on BMI and cancer risk, 
but the relationship between obesity and thyroid cancer 
stage or behavior remains unclear. Recently, Paes et al. [15] 
reported that a higher BMI was found not be associated 
with more aggressive tumor features or a greater like-
lihood of recurrence or persistence. Rather, they suggested 
that obesity may be correlated with a less aggressive tu-
mor invasion, though it was not significant. 
This study also found no statically significant difference 
between indices of body size and T and N stage. In neck 
lymph node metastasis, the group of positive metastasis 
had taller mean height, but there was no significant differ-
ence in multivariate analysis. Because the younger pa-
tients had an increased tendency to be taller than older pa-
tients, and the patients of positive lymph node metastasis 
were younger than the others. 
Since this study was a retrospective study, it was limited 
in that various biases could not be excluded. This study 
was also limited in that it could not represent the patients 
who underwent lobectomy of the thyroid (small size and 
solitary cancer) since the subjects were only selected from 
patients who underwent total thyroidectomy among the 
PTC patients. Moreover, because this study had short peri-
od of follow-up and was carried out with a relatively small 
group of patients, the prognosis was not directly com-
pared. 
In this study, our findings suggest that PTC severity and 
recurrence are not associated with indices of body size. A 
further confirmatory study should be conducted.
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